Multiparametric MRI for Prostate Cancer Detection: New Insights into the Combined Use of a Radiomic Approach with Advanced Acquisition Protocol
- PMID: 32046196
- PMCID: PMC7072162
- DOI: 10.3390/cancers12020390
Multiparametric MRI for Prostate Cancer Detection: New Insights into the Combined Use of a Radiomic Approach with Advanced Acquisition Protocol
Abstract
Prostate cancer (PCa) is a disease affecting an increasing number of men worldwide. Several efforts have been made to identify imaging biomarkers to non-invasively detect and characterize PCa, with substantial improvements thanks to multiparametric Magnetic Resonance Imaging (mpMRI). In recent years, diffusion kurtosis imaging (DKI) was proposed to be directly related to tissue physiological and pathological characteristic, while the radiomic approach was proven to be a key method to study cancer imaging phenotypes. Our aim was to compare a standard radiomic model for PCa detection, built using T2-weighted (T2W) and Apparent Diffusion Coefficient (ADC), with an advanced one, including DKI and quantitative Dynamic Contrast Enhanced (DCE), while also evaluating differences in prediction performance when using 2D or 3D lesion segmentation. The obtained results in terms of diagnostic accuracy were high for all of the performed comparisons, reaching values up to 0.99 for the area under a receiver operating characteristic curve (AUC), and 0.98 for both sensitivity and specificity. In comparison, the radiomic model based on standard features led to prediction performances higher than those of the advanced model, while greater accuracy was achieved by the model extracted from 3D segmentation. These results provide new insights into active topics of discussion, such as choosing the most convenient acquisition protocol and the most appropriate postprocessing pipeline to accurately detect and characterize PCa.
Keywords: PI-RADS; diffusion kurtosis imaging; dynamic contrast-enhanced magnetic resonance imaging; magnetic resonance imaging; prostate cancer; radiomics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.J Magn Reson Imaging. 2019 Mar;49(3):875-884. doi: 10.1002/jmri.26243. Epub 2018 Sep 19. J Magn Reson Imaging. 2019. PMID: 30230108 Free PMC article.
-
Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.Invest Radiol. 2015 Aug;50(8):483-9. doi: 10.1097/RLI.0000000000000155. Invest Radiol. 2015. PMID: 25867657
-
Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.Cancers (Basel). 2020 Jul 2;12(7):1767. doi: 10.3390/cancers12071767. Cancers (Basel). 2020. PMID: 32630787 Free PMC article.
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis.AJR Am J Roentgenol. 2018 Aug;211(2):358-368. doi: 10.2214/AJR.17.18934. Epub 2018 May 29. AJR Am J Roentgenol. 2018. PMID: 29812977
Cited by
-
Radiomics-based machine-learning method to diagnose prostate cancer using mp-MRI: a comparison between conventional and fused models.MAGMA. 2023 Feb;36(1):55-64. doi: 10.1007/s10334-022-01037-z. Epub 2022 Sep 17. MAGMA. 2023. PMID: 36114898
-
Precision Medicine in Radiomics and Radiogenomics.J Pers Med. 2022 Nov 1;12(11):1806. doi: 10.3390/jpm12111806. J Pers Med. 2022. PMID: 36579529 Free PMC article.
-
Value of machine learning-based transrectal multimodal ultrasound combined with PSA-related indicators in the diagnosis of clinically significant prostate cancer.Front Endocrinol (Lausanne). 2023 Mar 8;14:1137322. doi: 10.3389/fendo.2023.1137322. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36967794 Free PMC article.
-
MRI Based Radiomics Compared With the PI-RADS V2.1 in the Prediction of Clinically Significant Prostate Cancer: Biparametric vs Multiparametric MRI.Front Oncol. 2022 Jan 20;11:792456. doi: 10.3389/fonc.2021.792456. eCollection 2021. Front Oncol. 2022. PMID: 35127499 Free PMC article.
-
A two-stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach.J Med Radiat Sci. 2025 Mar;72(1):93-105. doi: 10.1002/jmrs.841. Epub 2024 Dec 19. J Med Radiat Sci. 2025. PMID: 39698957 Free PMC article.
References
-
- Hegde J.V., Mulkern R.V., Panych L.P., Fennessy F.M., Fedorov A., Maier S.E., Tempany C.M.C. Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J. Magn. Reson. Imaging. 2013;37:1035–1054. doi: 10.1002/jmri.23860. - DOI - PMC - PubMed
-
- Fütterer J.J., Briganti A., De Visschere P., Emberton M., Giannarini G., Kirkham A., Taneja S.S., Thoeny H., Villeirs G., Villers A. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur. Urol. 2015;68:1045–1053. doi: 10.1016/j.eururo.2015.01.013. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous